Back to top
more

Globus Medical (GMED)

(Delayed Data from NYSE)

$74.88 USD

74.88
686,225

+1.34 (1.82%)

Updated Nov 1, 2024 04:00 PM ET

After-Market: $74.90 +0.02 (0.03%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.10%
2Buy17.80%
3Hold9.50%
4Sell2.70%
5Strong Sell2.70%
S&P50011.20%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

2-Buy of 5   2      

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

C Value C Growth D Momentum D VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 32% (79 out of 250)

Industry: Medical - Instruments

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Zacks News

IART or GMED: Which Is the Better Value Stock Right Now?

by Zacks Equity Research

IART vs. GMED: Which Stock Is the Better Value Option?

Globus Medical (GMED) Up 10.1% Since Last Earnings Report: Can It Continue?

by Zacks Equity Research

Globus Medical (GMED) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

IART or GMED: Which Is the Better Value Stock Right Now?

by Zacks Equity Research

IART vs. GMED: Which Stock Is the Better Value Option?

Globus Medical (GMED) Q2 Earnings In Line, Revenue View Up

by Zacks Equity Research

Globus Medical's (GMED) spine business gains traction from solid worldwide growth in the second quarter.

Globus Medical (GMED) Q2 Earnings Match Estimates

by Zacks Equity Research

Globus Medical (GMED) delivered earnings and revenue surprises of 0.00% and 5.77%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?

Earnings Preview: Globus Medical (GMED) Q2 Earnings Expected to Decline

by Zacks Equity Research

Globus Medical (GMED) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Globus Medical (GMED) Down 13.9% Since Last Earnings Report: Can It Rebound?

by Zacks Equity Research

Globus Medical (GMED) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Globus Medical Reveals Positive Study Results for ExcelsiusGPS

by Zacks Equity Research

Results of the study of ExcelsiusGPS reached a milestone for Globus Medical (GMED) in the field of robotics-assisted, minimally invasive pedicle screw placement procedure

Globus Medical (GMED) Q1 Earnings Miss, Revenues Grow Y/Y (Revised)

by Zacks Equity Research

Globus Medical (GMED) management states that the first quarter of a year poses a seasonal challenge to the company's capital equipment, which grossly affects its sales in Q1.

Globus Medical (GMED) Q1 Earnings Miss Mark, Margins Weak

by Zacks Equity Research

Globus Medical (GMED) management states that the first quarter of a year poses a seasonal challenge to the company's capital equipment, which grossly affects its sales in Q1.

Globus Medical (GMED) Q1 Earnings and Revenues Miss Estimates

by Zacks Equity Research

Globus Medical (GMED) delivered earnings and revenue surprises of -12.20% and -1.90%, respectively, for the quarter ended March 2019. Do the numbers hold clues to what lies ahead for the stock?

Globus Medical (GMED) Reports Next Week: What Awaits?

by Zacks Equity Research

Globus Medical (GMED) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Globus Medical Global Base Solid, Pricing Scenario Bothers

by Zacks Equity Research

Globus Medical (GMED) is upbeat about its growth prospects in the current and the emerging global markets through a continual expansion of direct and distributor sales forces.

Globus Medical (GMED) Beats Q4 Earnings and Revenue Estimates

by Zacks Equity Research

Globus Medical (GMED) delivered earnings and revenue surprises of 7.50% and 0.22%, respectively, for the quarter ended December 2018. Do the numbers hold clues to what lies ahead for the stock?

Globus Medical (GMED) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

by Zacks Equity Research

Globus Medical (GMED) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Globus Medical (GMED) Surges: Stock Moves 7.1% Higher

by Zacks Equity Research

Globus Medical (GMED) saw a big move last session, as its shares jumped more than 7% on the day, amid huge volumes.

Nitish Marwah headshot

New Strong Buy Stocks for December 20th

by Nitish Marwah

Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List today:

Globus Medical (GMED) Q3 Earnings and Revenues Beat Estimates

by Zacks Equity Research

Globus Medical (GMED) delivered earnings and revenue surprises of 18.18% and 1.10%, respectively, for the quarter ended September 2018. Do the numbers hold clues to what lies ahead for the stock?

Globus Medical (GMED) Reports Next Week: Wall Street Expects Earnings Growth

by Zacks Equity Research

Globus Medical (GMED) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Will Globus Medical (GMED) Beat Estimates Again in Its Next Earnings Report?

by Zacks Equity Research

Globus Medical (GMED) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

    ITGR vs. GMED: Which Stock Is the Better Value Option?

    by Zacks Equity Research

    ITGR vs. GMED: Which Stock Is the Better Value Option?

      ITGR vs. GMED: Which Stock Should Value Investors Buy Now?

      by Zacks Equity Research

      ITGR vs. GMED: Which Stock Is the Better Value Option?

        Opko Health (OPK) in Focus: Stock Moves 6% Higher

        by Zacks Equity Research

        Shares of Opko Health (OPK) rose nearly 6% on Friday.

          Globus Medical (GMED) Looks Good: Stock Adds 7.5% in Session

          by Zacks Equity Research

          Globus Medical (GMED) saw its shares rise nearly 8% on the day after the company reported year-over-year growth in third-quarter earnings and revenues.

            Globus Medical (GMED) Q3 Earnings In Line, View Reiterated

            by Zacks Equity Research

            Globus Medical (GMED) reports in-line third-quarter numbers on the back of higher revenues from core international business.